Lilly is now selling $12.9 billion of GLP-1 drugs every three months and expects to sell even more
Fast facts
- Category: Business
- Language: EN
- Published: 2026-04-30 07:25 UTC
- Sources: MarketWatch
Eli Lilly reported a strong quarter for its tirzepatide franchise, with sales reaching $12.9 billion every three months.
Why it matters
- This update can influence the Business agenda over the next 24-48 hours.
- It is based on 1 source, which helps cross-check key claims quickly.
- Watch follow-up statements and market/public response to assess real impact.